Boeing Company (The) (BA) › Analysis

Boeing Company (The) (BA) stock analysis, February 20, 2026: Boeing tests $230 support after 3.23% slide despite record backlog

Published February 20, 2026 · BA chart, levels and live analysis

Key Updates

Boeing shares declined 3.23% to $233.71 since the February 12 report, extending the pullback from recent highs despite positive operational momentum. The stock now trades 5.0% below Morningstar's $246 fair value estimate, with YTD gains compressing to 7.64% as short-term weakness overshadows strong delivery performance and ambitious production expansion plans. The investment thesis remains intact but faces near-term headwinds from execution risks associated with aggressive production ramp-up targets and persistent competitive concerns in the narrow-body segment.

Current Trend

Boeing has established a short-term downtrend with consecutive declines of 2.18% (1-day), 1.08% (5-day), and 6.14% (1-month), indicating profit-taking after the post-earnings rally. The stock maintains a 7.64% YTD gain and 3.87% advance over six months, demonstrating resilience despite recent weakness. Key resistance has formed at the $241-246 range (previous highs and fair value estimate), while support appears at the $230-233 level. The current price of $233.71 represents a critical test of this support zone, with technical momentum favoring further consolidation before the next directional move.

Investment Thesis

The investment thesis centers on Boeing's operational recovery and cash flow generation as production rates normalize following years of crisis. With 600 commercial deliveries in 2025 (highest since 2018) and a record $682 billion backlog representing over 6,100 aircraft, Boeing possesses substantial revenue visibility through 2030. The completed Spirit AeroSystems acquisition addresses critical supply chain quality issues, with defects down 60% since enhanced inspections began. Morningstar projects approximately $3 billion in free cash flow for 2026, potentially reaching $10 billion by 2028, supporting debt reduction from the current $54.1 billion level. The thesis assumes successful execution of 737 MAX production increases to 63 units monthly and 777X certification in late 2026, both critical to achieving projected cash flows and justifying the 25x 2026 EBITDA valuation.

Thesis Status

The investment thesis remains fundamentally sound but faces elevated execution risk. Positive developments include 46 January deliveries (third-highest on record) and 103 net new orders, demonstrating continued market demand and operational momentum. However, concerns about Boeing's long-term competitive position in the narrow-body segment and the ambitious nature of plans to reach record 63 units monthly production introduce uncertainty. The 40% reduction in supplier-related repair hours and Spirit integration progress support the operational recovery narrative, but the company must demonstrate sustained quality improvements while simultaneously scaling production. Current valuation at $233.71 versus $246 fair value suggests modest upside, contingent on flawless execution of production ramp-up and 777X certification timelines.

Key Drivers

Production Expansion Plans: Boeing is planning to increase 737 production to a record 63 jets monthly, with output expected to rise approximately 15% over the next 18 months. The company has installed tooling for a new final assembly line and is hiring mechanics and engineers to support mid-year manufacturing startup. This represents the most aggressive production target in Boeing's history and is essential for achieving projected cash flows and debt reduction.

Supply Chain Quality Improvements: Boeing achieved a 40% reduction in hours spent fixing supplier-related problems, with Spirit AeroSystems defects declining 60% since enhanced quality control inspections began in 2024. The December completion of Spirit's acquisition brings critical fuselage manufacturing under direct Boeing control, addressing the root cause of the January 2024 door plug incident that triggered FAA production caps.

Strong Delivery and Order Momentum: January 2026 deliveries of 46 aircraft marked the third-highest January total in company history, significantly outpacing Airbus's 19 deliveries. Boeing secured 103 net new orders versus Airbus's 49, including major commitments from Aviation Capital Group (50 737 MAX), Air India (30 737s), and Delta Air Lines (30 787s), demonstrating sustained market confidence.

Balance Sheet and Cash Flow Trajectory: Boeing generated $1.3 billion operating cash flow and $0.4 billion free cash flow in Q4 2025, ending the quarter with $29.4 billion in cash and marketable securities against $54.1 billion in debt. Morningstar projects approximately $3 billion in free cash flow for 2026, potentially reaching $10 billion by 2028, contingent on production scaling and 777X certification.

Competitive Position Concerns: Analysis suggests Boeing is focused on catching up with past performance rather than planning for future market demands, particularly regarding the aging 737 platform. The article warns Boeing may be repeating mistakes of former competitors by failing to develop adequate follow-on products, raising strategic questions about long-term competitiveness in the narrow-body segment.

Technical Analysis

Boeing trades at $233.71, down 3.23% from the February 12 close of $241.52 and testing critical support at the $230-233 level. The stock has formed a clear resistance zone at $241-246, corresponding to recent highs and Morningstar's fair value estimate. Short-term momentum indicators suggest continued weakness, with consecutive daily, weekly, and monthly declines indicating profit-taking pressure. The 7.64% YTD gain remains intact, providing a cushion above the $217 level (year-end 2025 implied price). Volume patterns suggest institutional repositioning rather than fundamental deterioration. A break below $230 would target the $220-225 support zone, while reclaiming $241 would signal resumption of the post-earnings uptrend toward the $246-250 range. The current consolidation appears healthy following the strong Q4 earnings rally, with the $230-246 range likely defining trading parameters until the next catalyst emerges.

Bull Case

Bear Case

Get a message when the BA picture changes — the agent team watches the levels and the news for you.Create a free account

More BA analyses